Middle East & Africa Upstream Bioprocessing Market Size & Outlook
Middle East & Africa upstream bioprocessing market, 2018-2030 (US$M)
Related Markets
MEA upstream bioprocessing market highlights
- The MEA upstream bioprocessing market generated a revenue of USD 758.5 million in 2023.
- The market is expected to grow at a CAGR of 13.2% from 2024 to 2030.
- In terms of segment, bioreactors/fermenters was the largest revenue generating product in 2023.
- Cell Culture Products is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 758.5 million |
| Market revenue in 2030 | USD 1,807.1 million |
| Growth rate | 13.2% (CAGR from 2023 to 2030) |
| Largest segment | Bioreactors/fermenters |
| Fastest growing segment | Cell Culture Products |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.1% of the global upstream bioprocessing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 18,040.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Upstream Bioprocessing Market Scope
Upstream Bioprocessing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa upstream bioprocessing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.
Bioreactors/fermenters was the largest segment with a revenue share of 33.08% in 2023. Horizon Databook has segmented the Middle East & Africa upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.
MEA’s upstream bioprocessing market holds the lowest market revenue share, as this industry is at a nascent stage in the current global scenario. However, growing awareness about biopharmaceuticals, especially biosimilar products, in this region is expected to drive the demand for upstream processes.
However, the approval rate of a biosimilar is lower in this region with only around five biosimilar products approved in Saudi Arabia which indicates lucrative opportunities for market growth over the forecast period. Efforts are being undertaken to streamline the process in Saudi Arabia, where each department separately approves each new therapy for successful product-centric evaluation.
Reasons to subscribe to Middle East & Africa upstream bioprocessing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa upstream bioprocessing market databook
-
Our clientele includes a mix of upstream bioprocessing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa upstream bioprocessing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA upstream bioprocessing market size, by country, 2018-2030 (US$M)
Middle East & Africa Upstream Bioprocessing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
